| Literature DB >> 34202772 |
Andrea Svoradova1, Vladimir Zmrhal1, Eva Venusova1, Petr Slama1.
Abstract
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that adhere to plastic; express the specific markers CD29, CD44, CD73, CD90, and CD105; and produce cytokines and growth factors supporting and regulating hematopoiesis. MSCs have capacity for differentiating into osteocytes, chondrocytes, adipocytes, and myocytes. They are useful for research toward better understanding the pathogenic potential of the infectious bursal disease virus, mineralization during osteogenesis, and interactions between MSCs as a feeder layer to other cells. MSCs are also important for immunomodulatory cell therapy, can provide a suitable strategy model for coculture with pathogens causing dermatitis disorders in chickens, can be cultured in vitro with probiotics and prebiotics with a view to eliminate the feeding of antibiotic growth promoters, and offer cell-based meat production. Moreover, bone marrow-derived MSCs (BM-MSCs) in coculture with hematopoietic progenitor/stem cells (HPCs/HSCs) can support expansion and regulation of the hematopoiesis process using the 3D-culture system in future research in chickens. MSCs' several advantages, including ready availability, strong proliferation, and immune modulatory properties make them a suitable model in the field of stem cell research. This review summarizes current knowledge about the general characterization of MSCs and their application in chicken as a model organism.Entities:
Keywords: applications; chicken; culture; disease; mesenchymal stem cells; probiotics
Year: 2021 PMID: 34202772 PMCID: PMC8300106 DOI: 10.3390/ani11071883
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Multifunctional properties of chicken mesenchymal stem cells.
Comparison of chicken MSCs derived from different sources.
| Sources | Type of Digestive | Separation | Morphology | Confluency | Positive Markers | Negative Markers | Transcription Factors | References |
|---|---|---|---|---|---|---|---|---|
| Bone marrow | - | Ficoll-Hypaque (1.090 g/mL) | spindle-shaped | 14 days | CD44, CD90 CD105 | CD45 | PouV, Sox2, Nanog | [ |
| Percoll solution (1.073 g/mL) | spindle-shaped | 2–3 days | CD44, CD29, CD71, CD73 | CD31, CD34 | [ | |||
| Compact bones | 0.25% collagenase | spindle-shaped | 8–10 days | CD90, CD105, CD73, CD44 | CD31, CD34 CD45 | [ | ||
| Lung | 0.1% collagenase | spindle-shaped | 5–7 days | CD29, CD73, CD90, CD105 | CD34, CD45 | OCT-4 | [ | |
| 0.5 mg/mL collagenase type IV | Ficoll-Hypaque (1.090 g/mL) | spindle-shaped | 14 days | CD44, CD90, CD105 | PouV | [ | ||
| Wharton’s jelly | 0.1% collagenase type IV | fibroblast-like shaped | 5–6 days | CD29, CD44, CD71, CD73 | CD31, CD34 | [ |
Figure 2Disadvantages of commercial farming of livestock.